#news #biotech Chutes & Ladders—Alexion bids farewell to CMO Clancy in possible M&A pivot

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Alexion bids farewell to CMO Clancy in possible M&A pivot .Alexion replaces CFO Clancy in possible M&A push; Black Diamond nabs three new R&D execs; X4 Pharma founder Skerlj takes on R&D head duties.

from FierceBiotech: Biotech https://ift.tt/2VbJXkT

#news #biotech Nimbus hires Loh from Kymera to lead biology team

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Nimbus hires Loh from Kymera to lead biology team .Nimbus Therapeutics has hired Christine Loh to lead its biology team. Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

from FierceBiotech: Biotech https://ift.tt/2V4pjmR

#news #biotech HIV vaccine shows signs of cross-subtype protection

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: HIV vaccine shows signs of cross-subtype protection .The long-studied RV144 HIV vaccine regimen containing clades B and E inserts produced strong immune responses in South Africa, where clade C dominates, suggesting the vaccine may provide wider protection than previously believed.

from FierceBiotech: Biotech https://ift.tt/2Igr2Al

#news #biotech NIH set for $3B funding boost under Senate budget proposal

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: NIH set for $3B funding boost under Senate budget proposal .A Senate spending committee has proposed increasing the NIH’s budget by 7.7% in 2020. The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.

from FierceBiotech: Biotech https://ift.tt/2AwgkkD

#news #biotech After swinging the ax on staffers, Five Prime Therapeutics now loses CEO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After swinging the ax on staffers, Five Prime Therapeutics now loses CEO .Less than two years after taking the reins from founding chief Rusty Williams, Five Prime Therapeutics’ CEO Aron Knickerbocker is exiting the company.

from FierceBiotech: Biotech https://ift.tt/34VNCb4

#news #biotech The next agricultural revolution is here

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: The next agricultural revolution is here .As a growing population and climate change threaten food security, researchers around the world are working to overcome the challenges that threaten the dietary needs of humans and livestock. A pair of scientists is now making the case that the knowledge and tools exist to facilitate the next agricultural revolution we so desperately need.

from Biotechnology News – Biology News https://ift.tt/30D23xv

#news #biotech Grains in the rain: New study opens the door to flood resistant crops

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Grains in the rain: New study opens the door to flood resistant crops .Of the major food crops, only rice is currently able to survive flooding. Thanks to new research, that could soon change—good news for a world in which rains are increasing in both frequency and intensity.

from Biotechnology News – Biology News https://ift.tt/2LZ8w0e

#news #biotech Biologists untangle growth and defense in maize, define key antibiotic pathways

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biologists untangle growth and defense in maize, define key antibiotic pathways .In order to meet the demands of growing human populations, agricultural production must double within the next 30 years. Yet the health of today’s crops and the promise of their yield face a rising slate of threats—from pests to chaotic weather events—leading to an urgent need to identify effective, natural plant defense strategies.

from Biotechnology News – Biology News https://ift.tt/331TBth

#news #biotech How an arthritis drug from Roche’s library could repair damaged hearts

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: How an arthritis drug from Roche’s library could repair damaged hearts .Scientists at Vanderbilt University say they’ve found a potential way to improve the process by which the heart repairs itself after a heart attack, and it comes from an unlikely source—a compound in Roche’s library that was initially designed to treat rheumatoid arthritis.

from FierceBiotech: Biotech https://ift.tt/2ObsbwQ